Many studies on the subject with widely varying methodologies have been done, but this review, published online in BMJ, considered only those that rated emotional distress before treatment, and compared the rates in women who did and did not become pregnant afterward.
Finally, the PIMs were evaluated in MFCs for energy production and wastewater treatment and compared with Nafion®117.
Data were collected at baseline and after 3 months of treatment and compared with baseline data for 25 age-matched healthy subjects.
The following biomarkers were assessed during oseltamivir treatment and compared to pre-treatment levels: serum creatinine, electrolytes, liver transaminases (AST, ALT), alkaline phosphatase, total bilirubin level and full blood count.
Under this study we took into consideration the diary noted in the second month of the last quarter of the treatment and compared it to the one written during the pretreatment.
The objective of this study was to investigate the cephalometric changes of 24 patients treated with FRD in conjunction with comprehensive orthodontic treatment and compared to untreated subjects who were matched in age, sex, and craniofacial morphology.
No previous trials have investigated the efficacy of supervised pelvic floor muscle training in combination with conservative treatment and compared this to an attention-control massage treatment including conservative treatment.
In this study, we examined the efficacy and safety of lower dose (1 mg/kg/day) of rosiglitazone, a thiazolidinedione, in combination with 5 mg/kg/day dose of LAF-237 (vildagliptin), a known DPP IV inhibitor, in aged db/db mice after 14 days of treatment and compared the combination with therapeutic dose (10 mg/kg) of rosiglitazone.
To investigate the effect of inhaled corticosteroids, similar miRNA expression analysis was performed on asthmatic airway biopsy samples following budesonide treatment and compared to pre-treatment samples.
mRNA was extracted from TET-ON/OFF-TRE50 cells after doxycycline treatment, and compared with mRNA extracted from TET-ON/OFF cells either uninfected or exposed to wild-type virions (Fig. 5a).
Proliferation and apoptosis in response to Lestaurtinib of cultured HL cells was evaluated in all HL cell lines after 48 h of treatment and compared to cells treated with DMSO vehicle control (normalized to 100%).
